» Articles » PMID: 6880629

Contrast Sensitivity in Evaluation of Visual Impairment Due to Macular Degeneration and Optic Nerve Lesions

Overview
Specialty Ophthalmology
Date 1983 Apr 1
PMID 6880629
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Spatial contrast sensitivity was investigated in a group of 17 patients with macular degeneration or optic atrophy. It has been reported earlier that patients with optic atrophy may have reduced contrast sensitivity at low spatial frequencies without decrease of visual acuity, a phenomenon called 'hidden visual loss'. The present study shows that also the opposite may be true: patients with macular degeneration or optic atrophy may have greatly decreased visual acuity and yet normal or nearly normal contrast sensitivity at low spatial frequencies and reasonably good sensitivity at intermediate spatial frequencies. This phenomenon could be called 'hidden vision'. In normal individuals and many visually impaired patients the spatial contrast sensitivity at high and intermediate spatial frequencies is equal when measured using grating fields of different size. In patients with central scotoma due to macular degeneration or optic atrophy contrast sensitivity is dependent on the size of the grating field: the maximal contrast sensitivity is higher when larger grating fields are used. The size of the smallest grating field that is needed for normal contrast sensitivity values at low spatial frequencies is one measure of visual impairment in this group of patients. Another measure of the function of the eccentric viewing area is the grating acuity which may also vary as a function of the grating field size.

Citing Articles

Impact of intravitreal injection therapy on contrast sensitivity in patients with nAMD and DME.

Dieke S, Wurche S, Ruebsam A, Wirbelauer C, Joussen A, Winterhalter S Graefes Arch Clin Exp Ophthalmol. 2023; 261(7):1823-1833.

PMID: 36622409 PMC: 10272247. DOI: 10.1007/s00417-022-05944-8.


Retinal structure-function correlation in type 2 diabetes.

Srinivasan S, Sivaprasad S, Rajalakshmi R, Anjana R, Malik R, Kulothungan V Eye (Lond). 2021; 36(10):1865-1871.

PMID: 34462581 PMC: 9500073. DOI: 10.1038/s41433-021-01761-1.


Functional changes following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy.

Zuo C, Wen F, Li J, Liu Y, Long S, Huang S Graefes Arch Clin Exp Ophthalmol. 2009; 248(2):191-6.

PMID: 19830442 DOI: 10.1007/s00417-009-1210-7.


Contrast sensitivity testing in clinical practice.

Hyvarinen L Br J Ophthalmol. 1995; 79(9):867-8.

PMID: 7488614 PMC: 505281. DOI: 10.1136/bjo.79.9.867.


The objective assessment of contrast sensitivity function by electrophysiological means.

Howe J, Mitchell K Br J Ophthalmol. 1984; 68(9):626-38.

PMID: 6466591 PMC: 1040430. DOI: 10.1136/bjo.68.9.626.